chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, SARS-CoV-2 test positive
Clinical narrative: diagnosed with covid; felt very terrible; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (diagnosed with covid) and ILLNESS (felt very terrible) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced SARS-COV-2 TEST POSITIVE (diagnosed with covid) and ILLNESS (felt very terrible). At the time of the report, SARS-COV-2 TEST POSITIVE (diagnosed with covid) and ILLNESS (felt very terrible) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site rash
Clinical narrative: red rash that goes from the injection site down to their elbow; tenderness; red rash that goes from the injection site down to their elbow; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (red rash that goes from the injection site down to their elbow), VACCINATION SITE PAIN (tenderness) and VACCINATION SITE ERYTHEMA (red rash that goes from the injection site down to their elbow) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No concomitant medications provided.  Concurrent medical conditions included COPD, Blood pressure abnormal and Thyroid disorder NOS.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE RASH (red rash that goes from the injection site down to their elbow), VACCINATION SITE PAIN (tenderness) and VACCINATION SITE ERYTHEMA (red rash that goes from the injection site down to their elbow). At the time of the report, VACCINATION SITE RASH (red rash that goes from the injection site down to their elbow), VACCINATION SITE PAIN (tenderness) and VACCINATION SITE ERYTHEMA (red rash that goes from the injection site down to their elbow) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included inhalers for COPD, blood pressure and thyroid medicine.  Treatment information was not provided. Patient had  first dose of the Moderna COVID-19 vaccine last week on Wednesday (10Mar2021) and still had a red rash on their arm that goes from the injection site down to elbow and there's still some tenderness. did not have any fever or anything else. Uses inhalers for their COPD and takes blood pressure and thyroid medicine.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling hot, Muscle spasms, Myalgia
Clinical narrative: in bed for 48 hours; spasm; hot/hot on the outside; mild spasms in the limbs; muscles aches in back/ muscle aches in neck; felt tired/fatigue; chills; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (hot/hot on the outside), MUSCLE SPASMS (mild spasms in the limbs), MYALGIA (muscles aches in back/ muscle aches in neck), FATIGUE (felt tired/fatigue) and VACCINATION COMPLICATION (in bed for 48 hours) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     patient medical history was not reported.  Concomitant products included CLOPIDOGREL, ATORVASTATIN and ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Feb-2021, the patient experienced CHILLS (chills). On 10-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MYALGIA (muscles aches in back/ muscle aches in neck) and FATIGUE (felt tired/fatigue). On 11-Mar-2021, the patient experienced FEELING HOT (hot/hot on the outside) and MUSCLE SPASMS (mild spasms in the limbs). On an unknown date, the patient experienced VACCINATION COMPLICATION (in bed for 48 hours) and MUSCLE SPASMS (spasm). On 09-Feb-2021, CHILLS (chills) had resolved. On 11-Mar-2021, MYALGIA (muscles aches in back/ muscle aches in neck) and FATIGUE (felt tired/fatigue) had resolved. On 12-Mar-2021, FEELING HOT (hot/hot on the outside) and MUSCLE SPASMS (mild spasms in the limbs) had resolved. At the time of the report, VACCINATION COMPLICATION (in bed for 48 hours) and MUSCLE SPASMS (spasm) outcome was unknown.            no treatment medications was reported patient medical history was not reported   This case was linked to MOD-2021-046390, MOD-2021-046390 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-Aug-2021: Significant follow-up appended: Concomitant medication was added. Newevents in bed for 48 hours and Spasm was added.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: in bed for 48 hours; spasm; hot/hot on the outside; mild spasms in the limbs; muscles aches in back/ muscle aches in neck; felt tired/fatigue; chills; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (hot/hot on the outside), MUSCLE SPASMS (mild spasms in the limbs), MYALGIA (muscles aches in back/ muscle aches in neck), FATIGUE (felt tired/fatigue) and VACCINATION COMPLICATION (in bed for 48 hours) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     patient medical history was not reported.  Concomitant products included CLOPIDOGREL, ATORVASTATIN and ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Feb-2021, the patient experienced CHILLS (chills). On 10-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MYALGIA (muscles aches in back/ muscle aches in neck) and FATIGUE (felt tired/fatigue). On 11-Mar-2021, the patient experienced FEELING HOT (hot/hot on the outside) and MUSCLE SPASMS (mild spasms in the limbs). On an unknown date, the patient experienced VACCINATION COMPLICATION (in bed for 48 hours) and MUSCLE SPASMS (spasm). On 09-Feb-2021, CHILLS (chills) had resolved. On 11-Mar-2021, MYALGIA (muscles aches in back/ muscle aches in neck) and FATIGUE (felt tired/fatigue) had resolved. On 12-Mar-2021, FEELING HOT (hot/hot on the outside) and MUSCLE SPASMS (mild spasms in the limbs) had resolved. At the time of the report, VACCINATION COMPLICATION (in bed for 48 hours) and MUSCLE SPASMS (spasm) outcome was unknown.            no treatment medications was reported patient medical history was not reported   This case was linked to MOD-2021-046390, MOD-2021-046390 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-Aug-2021: Significant follow-up appended: Concomitant medication was added. Newevents in bed for 48 hours and Spasm was added.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Rash
Clinical narrative: Formation of blisters on various parts of the body; Breaking up of the skin; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (Formation of blisters on various parts of the body) and RASH (Breaking up of the skin) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced BLISTER (Formation of blisters on various parts of the body) and RASH (Breaking up of the skin). The patient was treated with GRAMICIDIN, NEOMYCIN SULFATE, POLYMYXIN B SULFATE (NEOSPORINE) ongoing since an unknown date for Blisters, at an unspecified dose and frequency. At the time of the report, BLISTER (Formation of blisters on various parts of the body) and RASH (Breaking up of the skin) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. A patient called and reported that she received first doses of vaccine on 23 Feb 2021. After three days she reported to have breaking up of the skin and formation of blisters on various parts of the body. She applied some Neosporin to the blisters. She wanted to know whether she can take any other medications like a steroid for the blisters
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Heart rate, Pain in extremity, Palpitations
Clinical narrative: sore arm; my heart race; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and PALPITATIONS (my heart race) in a 79-year-old female patient who received mRNA-1273 for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and PALPITATIONS (my heart race). At the time of the report, PAIN IN EXTREMITY (sore arm) and PALPITATIONS (my heart race) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Mar-2021, Blood pressure measurement: 95 (Inconclusive) 95. On 02-Mar-2021, Heart rate: 177 (Inconclusive) 177.     The action taken with mRNA-1273 (Unknown) was unknown.       The patient reported that she was afraid to passed out if the she stands up, after being half an hour on the ground it went away.  No concomitant medications were provided by the reporter.  Treatment information was not provided. I had the moderna vaccine 3 weeks ago (1st of march). Next day at the morning (after the vaccination) had a sore arm, my heart race, my pulses were 177 and had pressure of 95. At the facility they told me that rapid heartbeats is something that a few patients had experienced. I was afraid to passed out if I stand up. aAfter being half an hour on the ground it went away. Do we need to wait for the second shot? Can we skip this dose and get two doses in a while? Like starting again the vaccination? Her daughter had a similar episode, she got the shot the same day as the caller. The next day her heart was racing.    This case was linked to MOD-2021-046625 (Patient Link).
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Pyrexia
Clinical narrative: headache; chills; fever; nausea; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), CHILLS (chills), PYREXIA (fever) and NAUSEA (nausea) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced HEADACHE (headache), CHILLS (chills), PYREXIA (fever) and NAUSEA (nausea). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. On 15-Mar-2021, CHILLS (chills), PYREXIA (fever) and NAUSEA (nausea) had resolved. At the time of the report, HEADACHE (headache) had not resolved. Not Provided          No concomitant medications were provided by the reporter. Patient stated she received the 2nd dose of Moderna on 14Mar2021 to the left, non-dominant arm. She reported that on the same day she started to have chills, fever, nausea and a headache. All the symptoms stopped on 15Mar2021 except the headache.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation irregular
Clinical narrative: Early Menstrual Period; This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUATION IRREGULAR (Early Menstrual Period) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015MZ0A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced MENSTRUATION IRREGULAR (Early Menstrual Period). On 13-May-2021, MENSTRUATION IRREGULAR (Early Menstrual Period) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication was reported. No treatment information was provided. Patient called in stating that she received the first dose of the Moderna COVID-19 vaccine on 26Feb2021. Following the administration of the vaccine the patient claims that her period started on 11Mar2021, which was 11-12 days sooner than normal. The caller did note that she received the vaccine while on her period which may be a correlation   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Patient said AE is resolved and they feel better now.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test
Clinical narrative: Received vaccine while pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Received vaccine while pregnant) in a 32-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015m20a and 011a21a) for COVID-19 vaccination.     The patient's past medical history included Alcohol use and Placenta previa (Live, pre-term birth). Concurrent medical conditions included Gestational diabetes and Cerebral palsy. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Pregnancy.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 31-Oct-2020 and the estimated date of delivery was 14-Jul-2021. On 04-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Received vaccine while pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirteenth week of the pregnancy. The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. On 04-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Received vaccine while pregnant) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Oct-2020, Pregnancy test: positive (Positive) Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided. Patient was subjected to ultrasound scan two times.
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Pregnancy test
Clinical narrative: EXPOSURE DURING PREGNANCY; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (EXPOSURE DURING PREGNANCY) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 10-Jun-2020 and the estimated date of delivery was 20-Mar-2021. On 08-Jul-2020, the patient experienced EXPOSURE DURING PREGNANCY (EXPOSURE DURING PREGNANCY). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-third week of the pregnancy.  At the time of the report, EXPOSURE DURING PREGNANCY (EXPOSURE DURING PREGNANCY) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Jul-2020, Pregnancy test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this 33 year-old female. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Chills, Erythema, Headache, Myalgia
Clinical narrative: Arm Swollen; Arm Hurting; Arm red; All Bones Ached; All Muscles Ached; Severe Headache; Chills; Fever; Neck Hurt; Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore Arm), NECK PAIN (Neck Hurt), PERIPHERAL SWELLING (Arm Swollen), PAIN IN EXTREMITY (Arm Hurting) and ERYTHEMA (Arm red) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore Arm). On 10-Mar-2021, the patient experienced NECK PAIN (Neck Hurt), BONE PAIN (All Bones Ached), MYALGIA (All Muscles Ached), HEADACHE (Severe Headache), CHILLS (Chills) and PYREXIA (Fever). On 11-Mar-2021, the patient experienced PERIPHERAL SWELLING (Arm Swollen), PAIN IN EXTREMITY (Arm Hurting) and ERYTHEMA (Arm red). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore Arm), NECK PAIN (Neck Hurt), PERIPHERAL SWELLING (Arm Swollen), PAIN IN EXTREMITY (Arm Hurting), ERYTHEMA (Arm red), BONE PAIN (All Bones Ached), MYALGIA (All Muscles Ached), HEADACHE (Severe Headache), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient had her 1st Shot 08MAR2021. On the first day, her arm was sore. The next day she had chills, fever, her neck was hurting, severe headache, all muscles and bones were aching and she had chills really bad. She took Tylenol and following day she had no chills she was still aching. Her arm was swollen, hurting and red from shoulder to elbow.   This case was linked to  INC.-MOD-2021-046455, INC.-MOD-2021-046518 (E2B Linked Report).; Sender's Comments:  INC.-MOD-2021-046455:Daughter case  INC.-MOD-2021-046518:Aunt case
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Pain in extremity, Peripheral swelling, Pyrexia
Clinical narrative: Arm Swollen; Arm Hurting; Arm red; All Bones Ached; All Muscles Ached; Severe Headache; Chills; Fever; Neck Hurt; Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore Arm), NECK PAIN (Neck Hurt), PERIPHERAL SWELLING (Arm Swollen), PAIN IN EXTREMITY (Arm Hurting) and ERYTHEMA (Arm red) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore Arm). On 10-Mar-2021, the patient experienced NECK PAIN (Neck Hurt), BONE PAIN (All Bones Ached), MYALGIA (All Muscles Ached), HEADACHE (Severe Headache), CHILLS (Chills) and PYREXIA (Fever). On 11-Mar-2021, the patient experienced PERIPHERAL SWELLING (Arm Swollen), PAIN IN EXTREMITY (Arm Hurting) and ERYTHEMA (Arm red). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore Arm), NECK PAIN (Neck Hurt), PERIPHERAL SWELLING (Arm Swollen), PAIN IN EXTREMITY (Arm Hurting), ERYTHEMA (Arm red), BONE PAIN (All Bones Ached), MYALGIA (All Muscles Ached), HEADACHE (Severe Headache), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient had her 1st Shot 08MAR2021. On the first day, her arm was sore. The next day she had chills, fever, her neck was hurting, severe headache, all muscles and bones were aching and she had chills really bad. She took Tylenol and following day she had no chills she was still aching. Her arm was swollen, hurting and red from shoulder to elbow.   This case was linked to  INC.-MOD-2021-046455, INC.-MOD-2021-046518 (E2B Linked Report).; Sender's Comments:  INC.-MOD-2021-046455:Daughter case  INC.-MOD-2021-046518:Aunt case
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Erythema, Limb discomfort, Pain, Paraesthesia
Clinical narrative: big red area like a soft ball size; pain; tingling sensation from under her arm to her chest-breast area; burning sensation; her arm felt funny; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (big red area like a soft ball size), PAIN (pain), PARAESTHESIA (tingling sensation from under her arm to her chest-breast area), BURNING SENSATION (burning sensation) and LIMB DISCOMFORT (her arm felt funny) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031620A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced ERYTHEMA (big red area like a soft ball size), PAIN (pain), PARAESTHESIA (tingling sensation from under her arm to her chest-breast area), BURNING SENSATION (burning sensation) and LIMB DISCOMFORT (her arm felt funny). At the time of the report, ERYTHEMA (big red area like a soft ball size), PAIN (pain), PARAESTHESIA (tingling sensation from under her arm to her chest-breast area), BURNING SENSATION (burning sensation) and LIMB DISCOMFORT (her arm felt funny) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications was reported Treatment information was not provided
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Body temperature, COVID-19, Diarrhoea
Clinical narrative: fever of 101 F; BP rose to 164/99 mm HG; Pulse 111 bpm; very hot to the touch; signs of flu or COVID; COVID; vomiting; has loose bowels; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 16-Mar-2021 and was forwarded to Moderna on 16-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (signs of flu or COVID), COVID-19 (COVID), VOMITING (vomiting), DIARRHOEA (has loose bowels) and PYREXIA (fever of 101 F) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     Concomitant products included PRAVASTATIN and VENLAFAXINE for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced INFLUENZA (signs of flu or COVID), COVID-19 (COVID), VOMITING (vomiting), DIARRHOEA (has loose bowels), BLOOD PRESSURE INCREASED (BP rose to 164/99 mm HG), HEART RATE INCREASED (Pulse 111 bpm) and FEELING HOT (very hot to the touch). On an unknown date, the patient experienced PYREXIA (fever of 101 F). At the time of the report, INFLUENZA (signs of flu or COVID), COVID-19 (COVID), VOMITING (vomiting), DIARRHOEA (has loose bowels), PYREXIA (fever of 101 F), BLOOD PRESSURE INCREASED (BP rose to 164/99 mm HG), HEART RATE INCREASED (Pulse 111 bpm) and FEELING HOT (very hot to the touch) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Mar-2021, Blood pressure measurement: 164/99 (High) 164/99mmHg. On 15-Mar-2021, Body temperature: 101 (High) 101 Degree Fahrenheit. On 15-Mar-2021, Heart rate: 111 (High) 111 bpm.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication information was provided.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling hot, Heart rate, Heart rate increased, Influenza, Pyrexia
Clinical narrative: fever of 101 F; BP rose to 164/99 mm HG; Pulse 111 bpm; very hot to the touch; signs of flu or COVID; COVID; vomiting; has loose bowels; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 16-Mar-2021 and was forwarded to Moderna on 16-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (signs of flu or COVID), COVID-19 (COVID), VOMITING (vomiting), DIARRHOEA (has loose bowels) and PYREXIA (fever of 101 F) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     Concomitant products included PRAVASTATIN and VENLAFAXINE for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced INFLUENZA (signs of flu or COVID), COVID-19 (COVID), VOMITING (vomiting), DIARRHOEA (has loose bowels), BLOOD PRESSURE INCREASED (BP rose to 164/99 mm HG), HEART RATE INCREASED (Pulse 111 bpm) and FEELING HOT (very hot to the touch). On an unknown date, the patient experienced PYREXIA (fever of 101 F). At the time of the report, INFLUENZA (signs of flu or COVID), COVID-19 (COVID), VOMITING (vomiting), DIARRHOEA (has loose bowels), PYREXIA (fever of 101 F), BLOOD PRESSURE INCREASED (BP rose to 164/99 mm HG), HEART RATE INCREASED (Pulse 111 bpm) and FEELING HOT (very hot to the touch) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Mar-2021, Blood pressure measurement: 164/99 (High) 164/99mmHg. On 15-Mar-2021, Body temperature: 101 (High) 101 Degree Fahrenheit. On 15-Mar-2021, Heart rate: 111 (High) 111 bpm.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication information was provided.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: fever of 101 F; BP rose to 164/99 mm HG; Pulse 111 bpm; very hot to the touch; signs of flu or COVID; COVID; vomiting; has loose bowels; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 16-Mar-2021 and was forwarded to Moderna on 16-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (signs of flu or COVID), COVID-19 (COVID), VOMITING (vomiting), DIARRHOEA (has loose bowels) and PYREXIA (fever of 101 F) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     Concomitant products included PRAVASTATIN and VENLAFAXINE for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced INFLUENZA (signs of flu or COVID), COVID-19 (COVID), VOMITING (vomiting), DIARRHOEA (has loose bowels), BLOOD PRESSURE INCREASED (BP rose to 164/99 mm HG), HEART RATE INCREASED (Pulse 111 bpm) and FEELING HOT (very hot to the touch). On an unknown date, the patient experienced PYREXIA (fever of 101 F). At the time of the report, INFLUENZA (signs of flu or COVID), COVID-19 (COVID), VOMITING (vomiting), DIARRHOEA (has loose bowels), PYREXIA (fever of 101 F), BLOOD PRESSURE INCREASED (BP rose to 164/99 mm HG), HEART RATE INCREASED (Pulse 111 bpm) and FEELING HOT (very hot to the touch) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Mar-2021, Blood pressure measurement: 164/99 (High) 164/99mmHg. On 15-Mar-2021, Body temperature: 101 (High) 101 Degree Fahrenheit. On 15-Mar-2021, Heart rate: 111 (High) 111 bpm.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication information was provided.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Inappropriate schedule of product administration
Clinical narrative: pregnant and received vaccine; Received second dose of vaccine 42 days after first dose; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 16-Mar-2021 and was forwarded to Moderna on 16-Mar-2021.    This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (pregnant and received vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received second dose of vaccine 42 days after first dose) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 025I20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was provided).   On 21-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 01-Oct-2021. On 01-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (pregnant and received vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received second dose of vaccine 42 days after first dose). On 01-Feb-2021, EXPOSURE DURING PREGNANCY (pregnant and received vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received second dose of vaccine 42 days after first dose) had resolved. Not Provided
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction, Therapy cessation
Clinical narrative: experiening lots of negative reactions that continues to this day; Consumer has decided not to proceed at this time with the second dose to complete the final vaccination process; This spontaneous case was reported by an other (subsequently medically confirmed) and describes the occurrence of ADVERSE REACTION (experiening lots of negative reactions that continues to this day) and THERAPY CESSATION (Consumer has decided not to proceed at this time with the second dose to complete the final vaccination process) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (experiening lots of negative reactions that continues to this day) and THERAPY CESSATION (Consumer has decided not to proceed at this time with the second dose to complete the final vaccination process). At the time of the report, ADVERSE REACTION (experiening lots of negative reactions that continues to this day) and THERAPY CESSATION (Consumer has decided not to proceed at this time with the second dose to complete the final vaccination process) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site pain, Injection site warmth, Swelling, Tenderness
Clinical narrative: tenderness; swelling; Redness; warm; Pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (tenderness), SWELLING (swelling), ERYTHEMA (Redness), INJECTION SITE WARMTH (warm) and INJECTION SITE PAIN (Pain at the injection site) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     Concomitant products included HYDROCHLOROTHIAZIDE, METOPROLOL and AMLODIPINE for an unknown indication.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INJECTION SITE PAIN (Pain at the injection site). On 17-Mar-2021, the patient experienced TENDERNESS (tenderness), SWELLING (swelling), ERYTHEMA (Redness) and INJECTION SITE WARMTH (warm). The patient was treated with BENZALKONIUM CHLORIDE, SODIUM CHLORIDE (ALIVE) at a dose of UNK dosage form. At the time of the report, TENDERNESS (tenderness), SWELLING (swelling), ERYTHEMA (Redness), INJECTION SITE WARMTH (warm) and INJECTION SITE PAIN (Pain at the injection site) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant meds include  Acetoarfarin lexiprol Action taken with mRNA-1273 in response to the events were Not Applicable
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: rashes on her entire body except face, arms,legs, neck,back,chest,belly; itching on both wrists; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching on both wrists) and RASH (rashes on her entire body except face, arms,legs, neck,back,chest,belly) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     Concomitant products included VITAMINS NOS, VITAMIN E NOS and MAGNESIUM for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced PRURITUS (itching on both wrists). On 13-Mar-2021, the patient experienced RASH (rashes on her entire body except face, arms,legs, neck,back,chest,belly). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Itchy skin, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Itchy skin, at an unspecified dose and frequency. At the time of the report, PRURITUS (itching on both wrists) and RASH (rashes on her entire body except face, arms,legs, neck,back,chest,belly) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: A red spot at the injection site; Itching at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching at the injection site) and VACCINATION SITE ERYTHEMA (A red spot at the injection site) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at the injection site). On 16-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (A red spot at the injection site). At the time of the report, VACCINATION SITE PRURITUS (Itching at the injection site) and VACCINATION SITE ERYTHEMA (A red spot at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products information was not reported. Treatment information was included cortisone cream. Patient stated that the red spot is not gone completely but is fading away
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Jaw disorder, Lymphadenopathy, Vaccination complication
Clinical narrative: Swollen lymph node in armpit; Malaise at injection site; Jaw popping; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION COMPLICATION (Malaise at injection site), JAW DISORDER (Jaw popping) and LYMPHADENOPATHY (Swollen lymph node in armpit) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     Concomitant products included AMLODIPINE and LOSARTAN for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced VACCINATION COMPLICATION (Malaise at injection site) and JAW DISORDER (Jaw popping). On 17-Mar-2021, the patient experienced LYMPHADENOPATHY (Swollen lymph node in armpit). On 15-Mar-2021, VACCINATION COMPLICATION (Malaise at injection site) and JAW DISORDER (Jaw popping) had resolved. At the time of the report, LYMPHADENOPATHY (Swollen lymph node in armpit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment  was provided.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: injection arm tenderness, nothing worse than any other vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (injection arm tenderness, nothing worse than any other vaccine) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 007M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Mar-2021, the patient experienced VACCINATION SITE PAIN (injection arm tenderness, nothing worse than any other vaccine). At the time of the report, VACCINATION SITE PAIN (injection arm tenderness, nothing worse than any other vaccine) outcome was unknown. Unknown          No concomitant medication was reported.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable  No treatment medication was reported.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Glossodynia
Clinical narrative: Sores on his tongue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of GLOSSODYNIA (Sores on his tongue) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038a21a) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced GLOSSODYNIA (Sores on his tongue). At the time of the report, GLOSSODYNIA (Sores on his tongue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications was reported Treatment information provided, mouth wash to treat the events
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore arm). At the time of the report, VACCINATION SITE PAIN (Sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant Product information was not provided. Treatment information was not provided.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Knee is killing me( left leg); This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Knee is killing me( left leg)) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Knee is killing me( left leg)). At the time of the report, ARTHRALGIA (Knee is killing me( left leg)) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported Treatment information were not provided  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Itchy; After 20 days, he had rashes on same arm.After few days, it started occurring in opposite arm; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy) and RASH (After 20 days, he had rashes on same arm.After few days, it started occurring in opposite arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Rash (The patient had rash in the different arm).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itchy) and RASH (After 20 days, he had rashes on same arm.After few days, it started occurring in opposite arm). At the time of the report, PRURITUS (Itchy) and RASH (After 20 days, he had rashes on same arm.After few days, it started occurring in opposite arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient taken medications but they didn't help. Concomitant product information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Warm; Hardness; Itchy; Swelling; Redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm), VACCINATION SITE INDURATION (Hardness), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE ERYTHEMA (Redness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No medical history reported by the reporter.  Concomitant products included SALBUTAMOL SULFATE (PROAIR [SALBUTAMOL SULFATE]) for an unknown indication.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warm), VACCINATION SITE INDURATION (Hardness), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE ERYTHEMA (Redness). At the time of the report, VACCINATION SITE WARMTH (Warm), VACCINATION SITE INDURATION (Hardness), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE ERYTHEMA (Redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.; Sender's Comments: Very limited information regarding these events has been provided at this time.  Further information has been requested.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Pain in extremity, Tenderness, Vaccination site erythema
Clinical narrative: Red halo around the arm at the site of injection; Warmth in the arm; Pain in the arm; Tenderness in the arm; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Warmth in the arm), PAIN IN EXTREMITY (Pain in the arm), TENDERNESS (Tenderness in the arm) and VACCINATION SITE ERYTHEMA (Red halo around the arm at the site of injection) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis. Concomitant products included PARACETAMOL (TYLENOL) for Chronic arthritis.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced FEELING HOT (Warmth in the arm), PAIN IN EXTREMITY (Pain in the arm) and TENDERNESS (Tenderness in the arm). On 03-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red halo around the arm at the site of injection). On 23-Feb-2021, FEELING HOT (Warmth in the arm), PAIN IN EXTREMITY (Pain in the arm) and TENDERNESS (Tenderness in the arm) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Red halo around the arm at the site of injection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient had a fine line that circled the deltoid where she received the vaccine